The insider purchases are small and likely routine, but the Registration Rights Agreement amendment granting Cynosure up to four demand registrations is a concrete catalyst for a secondary offering. Monitor for a Form S-1 or prospectus filing — if Cynosure exercises a demand right, the stock could face meaningful dilution. The non-cash director grants are standard compensation and carry no signal.
Price Chart
Executive Summary
Three BRCB insiders (CMO, COO, Principal Accounting Officer) made open-market purchases totaling ~$76K over a 7-day window, while six directors received non-cash stock grants. The purchases follow a May 15 amendment to the company's Registration Rights Agreement that grants Cynosure investors up to four demand registration rights, potentially signaling a near-term secondary offering.
Key Financial Metrics
Key Facts
- CMO Jessica Wegener-Beyer bought 3,100 shares at ~$6.46 for $20K on 2026-05-20
- COO Clay Geyer bought 933 shares at ~$6.86 for ~$6.4K on 2026-05-22
- Principal Accounting Officer Michael Schmidt bought 7,100 shares at ~$6.98 for $50K on 2026-05-20
- Six directors received non-cash stock grants totaling ~60,854 shares on 2026-05-27
- Total open-market purchases: ~$76K, or ~0.02% of $419M market cap
- Amendment to Registration Rights Agreement (filed 2026-05-20) grants Cynosure investors up to four demand registration rights
Financial Impact
Open-market purchases of ~$76K represent ~0.02% of market cap — trivial relative to company size
Risk Factors
- Cynosure investors may exercise demand registration rights, leading to a secondary offering and dilution
- The purchases are tiny relative to market cap and may be routine portfolio adjustments
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BRCB-1780009020310 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | Press Release | $9.81 | awaiting T+60 | — | $10.03 (+2.29%) |
Oct 9, 2026 17d ago | SC 13G | $7.25 | awaiting T+60 | — | $10.03 (+38.41%) |
Sep 25, 2026 4w ago | Press Release | $7.19 | awaiting T+60 | — | $10.03 (+39.57%) |
Sep 25, 2026 4w ago | Press Release | $7.19 | awaiting T+60 | — | $10.03 (+39.57%) |
Sep 11, 2026 6w ago | Press Release | $8.48 | awaiting T+60 | — | $10.03 (+18.34%) |
Sep 1, 2026 7w ago | Press Release | $9.54 | awaiting T+60 | — | $10.03 (+5.19%) |
Aug 28, 2026 8w ago | Press Release | $9.13 | awaiting T+60 | — | $10.03 (+9.91%) |
Aug 28, 2026 8w ago | Press Release | $9.13 | awaiting T+60 | — | $10.03 (+9.91%) |
Aug 11, 2026 10w ago | Press Release | $8.23 | awaiting T+60 | — | $10.03 (+21.93%) |
Jul 30, 2026 12w ago | Press Release | $7.97 $9.81 | ▲ +23.09% | ▲ +20.62% | $10.03 (+25.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers